AzTrials
AzTrials

Critically Ill PatientsNCT06543602

the Multi-modal Evaluation of Agitation in Critically Ill Patients Based on Remote Video-Ultra-sensitive Detection Wave

An observational study of Critically Ill Patients, run by Second Affiliated Hospital, Zhejiang University, School of Medicine at 2 sites in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study is to learn about the effectiveness of the multi-modal evaluation for agitation behavior in critically ill patients based on remote video-Ultra-sensitive detection wave. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Critically Ill Patients
What is being tested?
multi-model monitoring and alert
How many people
580 participants
Where
2 sitesChina
Study dates
1 May 2024to 30 Apr 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: any patients with agitation

Who may be able to join

  • Patients at risk of agitation in the ICU
  • Patients with RASS score -2 and above
  • ≦ 65 years old, ≧ 18 years old

Who cannot join

  • The affected party refused to participate in this study
  • Missing/incomplete information
  • Vulnerable groups such as pregnant women, those who lack the capacity for civil conduct and do not have the consent of their legal representatives
  • Maxillofacial trauma, burns, tumors, surgery, etc. affect facial expression
  • Patients with limb impairment and amputation
  • Spinal cord injury, limb movement/sensory limitations
Show all 11Show fewer
  • Patients with pre-existing neurological/psychiatric diseases
  • Patients with malignant tumors
  • Patients with infectious diseases
  • Patients with terminal disease and dying disease
  • Abnormal behavior due to head injury or craniocerebral disease

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

China2 sites, 1 recruiting
  • the second affiliated hospital, Zhejiang University school of medicine

    Hangzhou, Zhejiang, 310009

    Zexin Chen, 8657187783821, zeyykyb@163.com

    Yongan Xu, PhD& MD

    Recruiting
  • SAHZU

    Hanzhou, Zhejiang, 310009

    Active, not recruiting

Other trials in China

About this study

Official title: A Multi-modal Recognition Model and Efficacy Evaluation for Agitation Behavior in Critically Ill Patients Based on Remote -Ultra-sensitive Detection Wave ---A Multi-center, Open-label, Observational Study

The goal of this observational study is to learn about the effectiveness of the multi-modal evaluation for agitation behavior in critically ill patients based on remote video-Ultra-sensitive detection wave.

The main question it aims to answer is: evaluate the effectiveness of multi-modal evaluation monitoring system for agitated critically ill patients Participants already taking multi-modal evaluation monitoring system as part of their regular medical care for agitated critically ill patients will compare their effectiveness for agitation for 3 years.

Being tested
multi-model monitoring and alert
Keywords
Critically Ill, agitation, monitoring, remote
Medical subject headings
Critical Illness, Psychomotor Agitation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • multi-model monitoring and alertDiagnostic test

    All agitated critically illed patients are monitored by manual and multi-model monitoring and alert system

Study groups in NCT06543602
Study groupRoleWhat they receive
control group: monitoring by manual wayNot described
multiple-model monitoring group: agitation monitoring by remote video-radar waveNot described
Receives: Diagnostic Test: multi-model monitoring and alert

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. the correct rate for alerting agitated critically ill patients

    Measured: 10-15 seconds every agitated patients during stay in ICU

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Aug 2024
  2. Study start1 May 2024
  3. Primary completion30 Apr 2027 (estimated)
  4. Study completion30 Apr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
580 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06543602
Sponsor's protocol ID
2024 0135
Status last verified
Aug 2024
First submitted
5 Aug 2024
Last updated
9 Aug 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Critically Ill Patients, run by Second Affiliated Hospital, Zhejiang University, School of Medicine at 2 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 9 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

the correct rate for alerting agitated critically ill patients (time frame: 10-15 seconds every agitated patients during stay in ICU). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in